Slate Path Capital’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-145,000
| Closed | -$2.94M | – | 31 |
|
|
2017
Q3 | $2.94M | Buy |
+145,000
| New | +$2.94M | 0.15% | 22 |
|
|
2015
Q4 | – | Sell |
-735,000
| Closed | -$25.9M | – | 16 |
|
|
2015
Q3 | $25.9M | Sell |
735,000
-1,100,000
| -60% | -$38.7M | 2.97% | 9 |
|
|
2015
Q2 | $84.3M | Sell |
1,835,000
-100,000
| -5% | -$4.59M | 9.2% | 7 |
|
|
2015
Q1 | $90.7M | Sell |
1,935,000
-395,000
| -17% | -$18.5M | 5.72% | 8 |
|
|
2014
Q4 | $73.8M | Hold |
2,330,000
| – | – | 5.16% | 9 |
|
|
2014
Q3 | $55.2M | Buy |
+2,330,000
| New | +$55.2M | 2.48% | 12 |
|